The science, economics, and effectiveness of combination therapy for hepatitis C

被引：5

作者：

Dusheiko, G ^{[1
]}

Barnes, E ^{[1
]}

Webster, G ^{[1
]}

Whalley, S ^{[1
]}

机构：

[1] UCL Royal Free & Univ Coll Sch Med, London NW3 2QG, England

来源：

GUT | 2000年 / 47卷 / 02期

关键词：

D O I：

10.1136/gut.47.2.159

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：159 / 161

页数：3

共 20 条

[11] Rising incidence of hepatocellular carcinoma in the United States [J].

El-Serag, HB ;

Mason, AC .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :745-750

[12]

Heathcote EJ, 1999, HEPATOLOGY, V30, p316A

[13] Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions [J].

Khakoo, S ;

Glue, P ;

Grellier, L ;

Wells, B ;

Bell, A ;

Dash, C ;

Murray-Lyon, I ;

Lypnyj, D ;

Flannery, B ;

Walters, K ;

Dusheiko, GM .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (06) :563-570

[14] Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C [J].

McHutchison, JG ;

Gordon, SC ;

Schiff, ER ;

Shiffman, ML ;

Lee, WM ;

Rustgi, VK ;

Goodman, ZD ;

Ling, MH ;

Cort, S ;

Albrecht, JK .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1485-1492

[15] Natural history of liver fibrosis progression in patients with chronic hepatitis C [J].

Poynard, T ;

Bedossa, P ;

Opolon, P .

LANCET, 1997, 349 (9055) :825-832

[16] Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus [J].

Poynard, T ;

Marcellin, P ;

Lee, SS ;

Niederau, C ;

Minuk, GS ;

Ideo, G ;

Bain, V ;

Heathcote, J ;

Zeuzem, S ;

Trepo, C ;

Albrecht, J .

LANCET, 1998, 352 (9138) :1426-1432

[17] Interferon alfa for chronic hepatitis C infection - Reply [J].

Poynard, T .

LANCET, 1999, 353 (9151) :500-500

[18] In pursuit of quality: The National Institute for Clinical Excellence [J].

Rawlins, M .

LANCET, 1999, 353 (9158) :1079-1082

[19] Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients [J].

Simmonds, P ;

Mellor, J ;

Craxi, A ;

SanchezTapias, JM ;

Alberti, A ;

Prieto, J ;

Colombo, M ;

Rumi, MG ;

LoIacano, O ;

AmpurdanesMingall, S ;

FornsBernhardt, X ;

Chemello, L ;

Civeira, MP ;

Frost, C ;

Dusheiko, G .

JOURNAL OF HEPATOLOGY, 1996, 24 (05) :517-524

[20] Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus:: Implications for the development of broad spectrum anti-hepatitis virus agents [J].

Zitzmann, N ;

Mehta, AS ;

Carrouée, S ;

Butters, TD ;

Platt, FM ;

McCauley, J ;

Blumberg, BS ;

Dwek, RA ;

Block, TM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (21) :11878-11882

← 1 2 →